Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A review published in 2025 found that significant weight regain occurred after 8 weeks of stopping weight loss medication
In January 2026, the MHRA authorised an increase to a maximum weekly dose of 7.2 mg for certain adults with obesity
Scott Honken, Chief Commercial Officer at WeightWatchers, stated, By deepening our collaboration with Novo Nordisk, we are helping more people access the FDA-approved treatment they deserve, delivered within a holistic clinical model proven to support real, sustainable and improved health outcomes
Eli Lilly Files Suit Challenging the FDAs Drug Classification of Retatrutide On September 3, 2024, Eli Lilly filed a complaint against the FDA in the District Court for the Southern District of Indiana pursuing the latest challenge to the FDAs application of its biological product classification
